Author:
Stott C. G.,White L.,Wright S.,Wilbraham D.,Guy G. W.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference19 articles.
1. MHRA Public Assessment Report (2012) Nabiximols oromucosal spray (delta-9-tetrahydrocannabinol and cannabidiol)—PL 18024/0009; UK/H/2462/001/DC
2. Porteney R, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S, McQuade R, Wright S, Fallon MT (2012) Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain 13(5):438–449
3. Young CA, Nurmikko TJ, Rog DJ, Sanantis N (2005) A randomised controlled trial of Sativex, a cannabis based medicine, in central neuropathic pain due to multiple sclerosis. Program and abstracts of the 2005 Canadian Association of Physical Medicine and Rehabilitation Annual Meeting; Ottawa, Ontario, Canada. Abstract A45
4. Whittle BA, Guy GW, Robson P (2001) Prospects for new cannabis-based prescription medicines. J Cannabis Ther 1(3–4):183–205
5. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54(2):161–202
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献